Fresenius Medical Care Stock Gross Profit
| FME Stock | 42.52 0.55 1.31% |
Fresenius Medical Care fundamentals help investors to digest information that contributes to Fresenius Medical's financial success or failures. It also enables traders to predict the movement of Fresenius Stock. The fundamental analysis module provides a way to measure Fresenius Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Fresenius Medical stock.
Fresenius |
Fresenius Medical Care Company Gross Profit Analysis
Fresenius Medical's Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
Current Fresenius Medical Gross Profit | 5.31 B |
Most of Fresenius Medical's fundamental indicators, such as Gross Profit, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Fresenius Medical Care is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
| Competition |
According to the company disclosure, Fresenius Medical Care reported 5.31 B of gross profit. This is 136.73% higher than that of the Healthcare sector and significantly higher than that of the Medical Care Facilities industry. The gross profit for all Germany stocks is 80.6% higher than that of the company.
Fresenius Gross Profit Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Fresenius Medical's direct or indirect competition against its Gross Profit to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Fresenius Medical could also be used in its relative valuation, which is a method of valuing Fresenius Medical by comparing valuation metrics of similar companies.Fresenius Medical is one of the top stocks in gross profit category among its peers.
Fresenius Fundamentals
| Return On Equity | 0.0608 | |||
| Return On Asset | 0.0277 | |||
| Profit Margin | 0.03 % | |||
| Operating Margin | 0.08 % | |||
| Current Valuation | 21.57 B | |||
| Shares Outstanding | 293.41 M | |||
| Shares Owned By Insiders | 32.16 % | |||
| Shares Owned By Institutions | 38.63 % | |||
| Price To Book | 0.59 X | |||
| Price To Sales | 0.46 X | |||
| Revenue | 19.4 B | |||
| Gross Profit | 5.31 B | |||
| EBITDA | 3.2 B | |||
| Net Income | 894.33 M | |||
| Cash And Equivalents | 556.52 M | |||
| Total Debt | 7.17 B | |||
| Book Value Per Share | 47.68 X | |||
| Cash Flow From Operations | 2.17 B | |||
| Earnings Per Share | 2.34 X | |||
| Price To Earnings To Growth | 1.05 X | |||
| Target Price | 34.6 | |||
| Number Of Employees | 128.04 K | |||
| Beta | 0.9 | |||
| Market Capitalization | 10.4 B | |||
| Total Asset | 35.75 B | |||
| Z Score | 0.6 | |||
| Annual Yield | 0.03 % | |||
| Net Asset | 35.75 B | |||
| Last Dividend Paid | 1.12 |
About Fresenius Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Fresenius Medical Care's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Fresenius Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Fresenius Medical Care based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Fresenius Stock Analysis
When running Fresenius Medical's price analysis, check to measure Fresenius Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fresenius Medical is operating at the current time. Most of Fresenius Medical's value examination focuses on studying past and present price action to predict the probability of Fresenius Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fresenius Medical's price. Additionally, you may evaluate how the addition of Fresenius Medical to your portfolios can decrease your overall portfolio volatility.